351. Effect of natural compounds to inhibit human respiratory syncytial virus
- Author
-
Debanjan Mitra and Pradeep K. Mohapatra
- Abstract
Current COVID-19 effects are forcing us to think about other deadly viral diseases. Respiratory syncytial virus (RSV) is one of them. Every year thousands of children lost their lives due to respiratory diseases which are occurred by this RSV. Nowadays, bioactive compounds show an enormous effect on many deadly diseases and show excellent therapeutic effects. In this study, we have identified five bioactive compounds from the plant which will be used in the treatment of RSV. Molecular docking on the protein was done by Autodock. Hydrogen was added and routable bonds were fixed in the preparation time of protein for docking. All those compounds show their non-toxic nature which is evaluated by Lipinski's Rule of Five. Molecular docking on RSV matrix protein and surface glycoprotein with those bioactive compounds shows very promising results. Between all those compounds Baicalein appears as a lead compound. It shows -8.1 Kcal/mol in the case of matrix protein and -7.9 kcal/mol in the case of the surface glycoprotein of RSV. Due to its availability and non-toxic nature, it can be used in the treatment of RSV. AS it is derived from plants, it also has very fewer side effects than chemical drugs.
- Published
- 2021
- Full Text
- View/download PDF